In Reply In response to Pysyk’s inquiry about anesthesia use in our study,1 33% received general anesthesia, 8% received neuraxial anesthesia, and 55% in the other category received mostly local anesthesia/sedation. Use of postoperative continuous epidural analgesia was not documented but, as pointed out, coadministration of a direct oral anticoagulant (DOAC) with such analgesia is not recommended.2 Any surgery or procedure using neuraxial anesthesia was considered high bleed risk, with 2 days DOAC interruption, corresponding to a 60- to 68-hour interval between the last dose and surgery to allow sufficient time approximately 5 DOAC half-lives) for a minimal-to-no residual anticoagulant effect at surgery or procedure,3 resulting in 98.9% of patients with high bleed risk with DOAC levels less than 50 ng/mL.1
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Spyropoulos AC, Schulman S, Douketis JD. Epidural Catheter Use and Further Issues in Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant—Reply. JAMA Intern Med. 2020;180(2):333–334. doi:10.1001/jamainternmed.2019.5851
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: